Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Active not recruiting 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 3OTHER_GOV 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Other 5

Conditions

Obesity 373Neoplasms 134Breast Neoplasms 95Mucositis 94Overweight 91Sexual Dysfunction, Physiological 90Polycystic Ovary Syndrome 89Dyspnea 56Motor Activity 54Weight Loss 38Constipation 35Diabetes Mellitus 33Prostatic Neoplasms 32Head and Neck Neoplasms 30Colorectal Neoplasms 30Endometrial Neoplasms 26Lung Neoplasms 25Depression 25Diabetes Mellitus, Type 2 23Cardiovascular Diseases 23Multiple Endocrine Neoplasia Type 1 22Pain 20Anxiety Disorders 20Insulin Resistance 19Obesity, Morbid 18Pulmonary Disease, Chronic Obstructive 17Hypertension 17Sexual Dysfunctions, Psychological 16Metabolic Syndrome 16Colonic Neoplasms 16

Interventions

Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Chemotherapy-induced Peripheral Neuropathy × Other × Clear all
NCT05771974 2026-02-27

AIUR

Incheon St.Mary's Hospital

Phase NA Active not recruiting
104 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT05759052 2025-12-24

CIPN-LEA

University Hospital, Clermont-Ferrand

Completed
467 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT05371158 2025-08-15

QLIPP-CIPN

Tilburg University

Phase NA Terminated
112 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT06491082 2024-07-08

CIN

Swami Rama Himalayan University

Recruiting
124 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT04393363 2024-01-31

NOVIT1

Aalborg University Hospital

Active not recruiting
20 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡